Pregnanolone Glutamate: A Dual-Fate Delivery System for Neuroactive Steroids in Perinatal Focal Cerebral Ischemia
International Journal of Molecular Sciences · 09.03.2026 · 27 (5) · 2506
DOI: 10.3390/ijms27052506 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.03.2026. Verfasst von Grygoriy Tsenov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical Research Program, Division of Experimental Neurobiology, National Institute of Mental Health, 250 67 Klecany, Czech Republic. Hauptthemen laut MEDLINE: Pregnanolone, Brain Ischemia, Neurosteroids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Science Foundation (GAČR), Ministry of Health of the Czech Republic, Academy of Sciences of the Czech Republic.
Abstract (Originalsprache)
Pregnanolone glutamate (PG) is a synthetic neurosteroid analog showing promise for treating ischemic brain injury, yet its blood–brain barrier (BBB) transport and metabolic fate remain unclear. We investigated the pharmacokinetics of PG in postnatal day 12 rats of both sexes subjected to endothelin-1 (ET-1)-induced focal hippocampal ischemia. Animals received PG (1 mg/kg intraperitoneal (i.p.)) or vehicle; serum and hippocampal steroidomes were profiled 60 min post-administration using gas chromatography-tandem mass spectrometry (GC-MS/MS) (hippocampus: n = 16 PG+, n = 27 PG−; multi-tissue subset: n = 6 PG+, n = 21 PG−). Our data revealed a “dual-fate” mechanism: PG undergoes systemic hydrolysis as a prodrug, as suggested by the tissue distribution pattern at 60 min post-administration, but also crosses the BBB intact, with significant parent conjugate accumulation in the hippocampus (42.3 pmol/g). The brain functioned as a “metabolic sink”, passively accumulating metabolites generated in peripheral organs—such as 17-hydroxypregnanolone—despite local absence of synthesizing enzymes (e.g., CYP17A1). Crucially, PG induced “metabolic segregation” within the central nervous system (CNS): the pharmacological 5β-pathway was saturated (~170-fold pregnanolone increase), while endogenous neuroprotective 5α-pathway (allopregnanolone) homeostasis remained preserved, contrasting with peripheral metabolic saturation. Preferential hippocampal accumulation of 3-oxo and 3β-isomers suggests autonomous regulatory buffering via oxidative 17β-hydroxysteroid dehydrogenase (HSD17B) enzymes, protecting against excessive GABAergic inhibition. This unique pharmacokinetic profile—combining metabolic segregation with active central buffering—defines PG as a dual-mechanism delivery system that generates central neuroactive metabolites—several with previously established GABAergic and neuroprotective activity—without disrupting endogenous neurosteroidogenesis, positioning it as a promising neurotherapeutic candidate minimizing physiological steroid homeostasis disruption. Importantly, the present study characterizes the pharmacokinetic and metabolic fate of PG; the neuroprotective efficacy of PG was demonstrated in our prior functional studies using the same model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Preclinical Research Program, Division of Experimental Neurobiology, National Institute of Mental Health, 250 67 Klecany, Czech Republic.
- Department of Animal Physiology, Faculty of Science, Charles University, Albertov 6, 128 00 Prague, Czech Republic.
- Institute of Endocrinology, 110 00 Prague, Czech Republic.
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 160 00 Prague, Czech Republic.
- Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
ORCID-Profile: Iqra Bano, Eva Kudová, Martin Hill
Förderung
- Czech Science Foundation (GAČR)
- Ministry of Health of the Czech Republic
- Academy of Sciences of the Czech Republic
- European Regional Development Fund-Project
- European Regional Development Fund
- Ministry of Health of the Czech Republic Institutional Support
Zitieren
APA
Tsenov, G., Bano, I., Velíková, M., Kútna, V., Chodounská, H., Kudová, E., Bulant, J., & Hill, M. (2026). Pregnanolone Glutamate: A Dual-Fate Delivery System for Neuroactive Steroids in Perinatal Focal Cerebral Ischemia. International Journal of Molecular Sciences, 27(5), 2506. https://doi.org/10.3390/ijms27052506
Vancouver
Tsenov G, Bano I, Velíková M, Kútna V, Chodounská H, Kudová E, et al. Pregnanolone Glutamate: A Dual-Fate Delivery System for Neuroactive Steroids in Perinatal Focal Cerebral Ischemia. International Journal of Molecular Sciences. 2026;27(5):2506. doi:10.3390/ijms27052506
BibTeX
@article{Tsenov2026,
author = {Tsenov, Grygoriy and Bano, Iqra and Velíková, Marta and Kútna, Viera and Chodounská, Hana and Kudová, Eva and Bulant, Josef and Hill, Martin},
title = {Pregnanolone Glutamate: A Dual-Fate Delivery System for Neuroactive Steroids in Perinatal Focal Cerebral Ischemia},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2506},
doi = {10.3390/ijms27052506}
}
EUVIMED